Cargando…
Peripheral kynurenine-3-monooxygenase deficiency as a potential risk factor for metabolic syndrome in schizophrenia patients
Increased predisposition of schizophrenia patients (SP) to development of obesity and insulin resistance suggested common signaling pathway between metabolic syndrome (MetS) and schizophrenia. Deficiency of kynurenine-3-monooxygenase (KMO), enzyme catalyzing formation of 3-hydroxykynurenine (3-HK) f...
Autores principales: | Oxenkrug, Gregory, van der Hart, Marieke, Roeser, Julien, Summergrad, Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5523985/ https://www.ncbi.nlm.nih.gov/pubmed/28748226 |
Ejemplares similares
-
Peripheral kynurenines as biomarkers and targets for prevention and treatment of psychiatric conditions associated with SARS-CoV-2 infection
por: Oxenkrug, Gregory, et al.
Publicado: (2021) -
Tryptophan-Kynurenine Metabolism and Insulin Resistance in Hepatitis C Patients
por: Oxenkrug, G. F., et al.
Publicado: (2013) -
Kynurenic acid, an aryl hydrocarbon receptor ligand, is elevated in serum of Zucker fatty rats
por: Oxenkrug, G, et al.
Publicado: (2016) -
S11. PLASMA LEPTIN AND ANTHRANILIC ACID IN SCHIZOPHRENIA PATIENTS: NEW BIOMARKERS OF PREDISPOSITION TO METABOLIC ABNORMALITIES
por: Steiner, Johann, et al.
Publicado: (2020) -
The Kynurenine Pathway and Kynurenine 3-Monooxygenase Inhibitors
por: Hughes, Tamera D., et al.
Publicado: (2022)